Kai-Min Chu
Company: Sinew
Job title: Chief Executive Officer
Seminars:
Workshop D: Exploring Non-Invasive Tests & Biomarkers for MASH in Action 11:30 am
Delving into promising results for SNP-6 Series in treating MASH with multi-functional effects and a POC Quantitative Non-Invasive Test for MASH: Insights from animal and clinical trials. Showing clinically significant improvements in biomarkers of liver injury, inflammation, and fibrosis in a Phase 2 study in patients with MASH. Also exploring a case study of this…Read more
day: Clinical Track Workshop D